🇺🇸 FDA
Patent

US 9403819

Apoptosis signal-regulating kinase 1 inhibitors

granted A61PA61P1/00A61P1/02

Quick answer

US patent 9403819 (Apoptosis signal-regulating kinase 1 inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/16